REG - MJ Gleeson Plc - Total Voting Rights

MJ GLEESONAnnouncement

03/12/2019 16:10

RNS Number : 5529V
MJ Gleeson PLC
03 December 2019
 


3 December 2019
MJ Gleeson plc
(GLE.L)
 
Exercise of Options and Total Voting Rights
 
MJ Gleeson plc (GLE.L), the low cost housebuilder and strategic land specialist, announces that, further to the announcement on 2 December 2019, it has issued and allotted a total of 633,730 ordinary shares of 2 pence each in the Company ("Ordinary Shares").
Application has been made for the admission to trading of the 633,730 new Ordinary Shares on the Main Market of the London Stock Exchange and to listing on the Official List of the FCA, with dealings expected to commence at 8.00 a.m. on 6 December 2019.
Total Voting Rights
Following the issue of the new Ordinary Shares, which will rank pari passu with all existing Ordinary Shares, the total number of issued Ordinary Shares is 55,309,014. The Company does not hold any Ordinary Shares in Treasury.
Therefore, the total number of Ordinary Shares with voting rights is 55,309,014 which may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's DTR.
Enquiries:
MJ Gleeson plc                                                           Tel: 44 1142 612 900
James Thomson             Chief Executive Officer   
Stefan Allanson              Chief Financial Officer
 
Instinctif Partners                                                      Tel: 44 20 7457 2020
Mark Garraway
James Gray
 
N+1 Singer                                                                 Tel: 44 20 7496 3000
Shaun Dobson
Rachel Hayes
 
Liberum                                                                       Tel: 44 20 3100 2222
Neil Patel
Richard Bootle




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TVRLLFIRFLLVIIA